Reiko Nagai

Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial

Masaomi Nangaku, Takayuki Hamano, Tadao Akizawa et al. · American Journal of Nephrology · 2021 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial

Etsuro Mori, Manabu Ikeda, Reiko Nagai et al. · Alzheimer s Research & Therapy · 2015 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients

Hidetoshi Kanai, Masaomi Nangaku, Reiko Nagai et al. · Therapeutic Apheresis and Dialysis · 2021 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer

Hibiki Udagawa, Shunji Takahashi, Motohiro Hirao et al. · Cancer Medicine · 2022 · 16 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort

Norikazu Masuda, Makiko Ono, Toru Mukohara et al. · European Journal of Cancer · 2022 · 13 citations · Full text

Medicine, Oncology, Pharmacology +16